ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Poliomycetes Vaccine Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-18F9552
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Poliomycetes Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Poliomycetes Vaccine Market Research Report 2024

Code: QYRE-Auto-18F9552
Report
January 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
United Pharma Industries Co Ltd
Gansu Conbest Biotech Co., Ltd.
Shenzhen Mellow Hope Pharm Industrial Co., Ltd.
China National Biotec Group
Serum Institute of India

Poliomycetes Vaccine Market Size

The global Poliomycetes Vaccine market was valued at US$ 709.8 million in 2023 and is anticipated to reach US$ 835.1 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.

Poliomycetes Vaccine Market

Poliomycetes Vaccine Market

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2022.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Poliomycetes Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliomycetes Vaccine.

Report Scope

The Poliomycetes Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poliomycetes Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliomycetes Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Poliomycetes Vaccine Market Report

Report Metric Details
Report Name Poliomycetes Vaccine Market
Accounted market size in 2023 US$ 709.8 million
Forecasted market size in 2030 US$ 835.1 million
CAGR 2.3%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Type 1
  • Type 2
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi S.A, United Pharma Industries Co Ltd, Gansu Conbest Biotech Co., Ltd., Shenzhen Mellow Hope Pharm Industrial Co., Ltd., China National Biotec Group, Serum Institute of India
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Poliomycetes Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Poliomycetes Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Poliomycetes Vaccine Market growing?

Ans: The Poliomycetes Vaccine Market witnessing a CAGR of 2.3% during the forecast period 2024-2030.

What is the Poliomycetes Vaccine Market size in 2030?

Ans: The Poliomycetes Vaccine Market size in 2030 will be US$ 835.1 million.

Who are the main players in the Poliomycetes Vaccine Market report?

Ans: The main players in the Poliomycetes Vaccine Market are Sanofi S.A, United Pharma Industries Co Ltd, Gansu Conbest Biotech Co., Ltd., Shenzhen Mellow Hope Pharm Industrial Co., Ltd., China National Biotec Group, Serum Institute of India

What are the Application segmentation covered in the Poliomycetes Vaccine Market report?

Ans: The Applications covered in the Poliomycetes Vaccine Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Poliomycetes Vaccine Market report?

Ans: The Types covered in the Poliomycetes Vaccine Market report are Type 1, Type 2

1 Poliomycetes Vaccine Market Overview
1.1 Product Overview and Scope of Poliomycetes Vaccine
1.2 Poliomycetes Vaccine Segment by Type
1.2.1 Global Poliomycetes Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Type 1
1.2.3 Type 2
1.3 Poliomycetes Vaccine Segment by Application
1.3.1 Global Poliomycetes Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Poliomycetes Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliomycetes Vaccine Revenue 2019-2030
1.4.2 Global Poliomycetes Vaccine Sales 2019-2030
1.4.3 Global Poliomycetes Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Poliomycetes Vaccine Market Competition by Manufacturers
2.1 Global Poliomycetes Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Poliomycetes Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Poliomycetes Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Poliomycetes Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poliomycetes Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poliomycetes Vaccine, Product Type & Application
2.7 Poliomycetes Vaccine Market Competitive Situation and Trends
2.7.1 Poliomycetes Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Poliomycetes Vaccine Players Market Share by Revenue
2.7.3 Global Poliomycetes Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poliomycetes Vaccine Retrospective Market Scenario by Region
3.1 Global Poliomycetes Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Poliomycetes Vaccine Global Poliomycetes Vaccine Sales by Region: 2019-2030
3.2.1 Global Poliomycetes Vaccine Sales by Region: 2019-2024
3.2.2 Global Poliomycetes Vaccine Sales by Region: 2025-2030
3.3 Global Poliomycetes Vaccine Global Poliomycetes Vaccine Revenue by Region: 2019-2030
3.3.1 Global Poliomycetes Vaccine Revenue by Region: 2019-2024
3.3.2 Global Poliomycetes Vaccine Revenue by Region: 2025-2030
3.4 North America Poliomycetes Vaccine Market Facts & Figures by Country
3.4.1 North America Poliomycetes Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Poliomycetes Vaccine Sales by Country (2019-2030)
3.4.3 North America Poliomycetes Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Poliomycetes Vaccine Market Facts & Figures by Country
3.5.1 Europe Poliomycetes Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Poliomycetes Vaccine Sales by Country (2019-2030)
3.5.3 Europe Poliomycetes Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poliomycetes Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Poliomycetes Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Poliomycetes Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Poliomycetes Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Poliomycetes Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poliomycetes Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Poliomycetes Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Poliomycetes Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poliomycetes Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poliomycetes Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Poliomycetes Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Poliomycetes Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Poliomycetes Vaccine Sales by Type (2019-2030)
4.1.1 Global Poliomycetes Vaccine Sales by Type (2019-2024)
4.1.2 Global Poliomycetes Vaccine Sales by Type (2025-2030)
4.1.3 Global Poliomycetes Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Poliomycetes Vaccine Revenue by Type (2019-2030)
4.2.1 Global Poliomycetes Vaccine Revenue by Type (2019-2024)
4.2.2 Global Poliomycetes Vaccine Revenue by Type (2025-2030)
4.2.3 Global Poliomycetes Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Poliomycetes Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Poliomycetes Vaccine Sales by Application (2019-2030)
5.1.1 Global Poliomycetes Vaccine Sales by Application (2019-2024)
5.1.2 Global Poliomycetes Vaccine Sales by Application (2025-2030)
5.1.3 Global Poliomycetes Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Poliomycetes Vaccine Revenue by Application (2019-2030)
5.2.1 Global Poliomycetes Vaccine Revenue by Application (2019-2024)
5.2.2 Global Poliomycetes Vaccine Revenue by Application (2025-2030)
5.2.3 Global Poliomycetes Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Poliomycetes Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi S.A
6.1.1 Sanofi S.A Corporation Information
6.1.2 Sanofi S.A Description and Business Overview
6.1.3 Sanofi S.A Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi S.A Poliomycetes Vaccine Product Portfolio
6.1.5 Sanofi S.A Recent Developments/Updates
6.2 United Pharma Industries Co Ltd
6.2.1 United Pharma Industries Co Ltd Corporation Information
6.2.2 United Pharma Industries Co Ltd Description and Business Overview
6.2.3 United Pharma Industries Co Ltd Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 United Pharma Industries Co Ltd Poliomycetes Vaccine Product Portfolio
6.2.5 United Pharma Industries Co Ltd Recent Developments/Updates
6.3 Gansu Conbest Biotech Co., Ltd.
6.3.1 Gansu Conbest Biotech Co., Ltd. Corporation Information
6.3.2 Gansu Conbest Biotech Co., Ltd. Description and Business Overview
6.3.3 Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Product Portfolio
6.3.5 Gansu Conbest Biotech Co., Ltd. Recent Developments/Updates
6.4 Shenzhen Mellow Hope Pharm Industrial Co., Ltd.
6.4.1 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Corporation Information
6.4.2 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Description and Business Overview
6.4.3 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Product Portfolio
6.4.5 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Recent Developments/Updates
6.5 China National Biotec Group
6.5.1 China National Biotec Group Corporation Information
6.5.2 China National Biotec Group Description and Business Overview
6.5.3 China National Biotec Group Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 China National Biotec Group Poliomycetes Vaccine Product Portfolio
6.5.5 China National Biotec Group Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Poliomycetes Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Serum Institute of India Poliomycetes Vaccine Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poliomycetes Vaccine Industry Chain Analysis
7.2 Poliomycetes Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poliomycetes Vaccine Production Mode & Process
7.4 Poliomycetes Vaccine Sales and Marketing
7.4.1 Poliomycetes Vaccine Sales Channels
7.4.2 Poliomycetes Vaccine Distributors
7.5 Poliomycetes Vaccine Customers
8 Poliomycetes Vaccine Market Dynamics
8.1 Poliomycetes Vaccine Industry Trends
8.2 Poliomycetes Vaccine Market Drivers
8.3 Poliomycetes Vaccine Market Challenges
8.4 Poliomycetes Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
United Pharma Industries Co Ltd
Gansu Conbest Biotech Co., Ltd.
Shenzhen Mellow Hope Pharm Industrial Co., Ltd.
China National Biotec Group
Serum Institute of India
List of Tables
    Table 1. Global Poliomycetes Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Poliomycetes Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Poliomycetes Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Poliomycetes Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)
    Table 5. Global Poliomycetes Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Poliomycetes Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Poliomycetes Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Poliomycetes Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Poliomycetes Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Poliomycetes Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Poliomycetes Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Poliomycetes Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Poliomycetes Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomycetes Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Poliomycetes Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Poliomycetes Vaccine Sales by Region (2019-2024) & (K Doses)
    Table 18. Global Poliomycetes Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Poliomycetes Vaccine Sales by Region (2025-2030) & (K Doses)
    Table 20. Global Poliomycetes Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Poliomycetes Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Poliomycetes Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Poliomycetes Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Poliomycetes Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Poliomycetes Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Poliomycetes Vaccine Sales by Country (2019-2024) & (K Doses)
    Table 27. North America Poliomycetes Vaccine Sales by Country (2025-2030) & (K Doses)
    Table 28. North America Poliomycetes Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Poliomycetes Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Poliomycetes Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Poliomycetes Vaccine Sales by Country (2019-2024) & (K Doses)
    Table 32. Europe Poliomycetes Vaccine Sales by Country (2025-2030) & (K Doses)
    Table 33. Europe Poliomycetes Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Poliomycetes Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Poliomycetes Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Poliomycetes Vaccine Sales by Region (2019-2024) & (K Doses)
    Table 37. Asia Pacific Poliomycetes Vaccine Sales by Region (2025-2030) & (K Doses)
    Table 38. Asia Pacific Poliomycetes Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Poliomycetes Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Poliomycetes Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Poliomycetes Vaccine Sales by Country (2019-2024) & (K Doses)
    Table 42. Latin America Poliomycetes Vaccine Sales by Country (2025-2030) & (K Doses)
    Table 43. Latin America Poliomycetes Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Poliomycetes Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Poliomycetes Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Poliomycetes Vaccine Sales by Country (2019-2024) & (K Doses)
    Table 47. Middle East & Africa Poliomycetes Vaccine Sales by Country (2025-2030) & (K Doses)
    Table 48. Middle East & Africa Poliomycetes Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Poliomycetes Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Poliomycetes Vaccine Sales (K Doses) by Type (2019-2024)
    Table 51. Global Poliomycetes Vaccine Sales (K Doses) by Type (2025-2030)
    Table 52. Global Poliomycetes Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Poliomycetes Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Poliomycetes Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Poliomycetes Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Poliomycetes Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Poliomycetes Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Poliomycetes Vaccine Price (USD/Dose) by Type (2019-2024)
    Table 59. Global Poliomycetes Vaccine Price (USD/Dose) by Type (2025-2030)
    Table 60. Global Poliomycetes Vaccine Sales (K Doses) by Application (2019-2024)
    Table 61. Global Poliomycetes Vaccine Sales (K Doses) by Application (2025-2030)
    Table 62. Global Poliomycetes Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Poliomycetes Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Poliomycetes Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Poliomycetes Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Poliomycetes Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Poliomycetes Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Poliomycetes Vaccine Price (USD/Dose) by Application (2019-2024)
    Table 69. Global Poliomycetes Vaccine Price (USD/Dose) by Application (2025-2030)
    Table 70. Sanofi S.A Corporation Information
    Table 71. Sanofi S.A Description and Business Overview
    Table 72. Sanofi S.A Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 73. Sanofi S.A Poliomycetes Vaccine Product
    Table 74. Sanofi S.A Recent Developments/Updates
    Table 75. United Pharma Industries Co Ltd Corporation Information
    Table 76. United Pharma Industries Co Ltd Description and Business Overview
    Table 77. United Pharma Industries Co Ltd Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 78. United Pharma Industries Co Ltd Poliomycetes Vaccine Product
    Table 79. United Pharma Industries Co Ltd Recent Developments/Updates
    Table 80. Gansu Conbest Biotech Co., Ltd. Corporation Information
    Table 81. Gansu Conbest Biotech Co., Ltd. Description and Business Overview
    Table 82. Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 83. Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Product
    Table 84. Gansu Conbest Biotech Co., Ltd. Recent Developments/Updates
    Table 85. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Corporation Information
    Table 86. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Description and Business Overview
    Table 87. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 88. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Product
    Table 89. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Recent Developments/Updates
    Table 90. China National Biotec Group Corporation Information
    Table 91. China National Biotec Group Description and Business Overview
    Table 92. China National Biotec Group Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 93. China National Biotec Group Poliomycetes Vaccine Product
    Table 94. China National Biotec Group Recent Developments/Updates
    Table 95. Serum Institute of India Corporation Information
    Table 96. Serum Institute of India Description and Business Overview
    Table 97. Serum Institute of India Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 98. Serum Institute of India Poliomycetes Vaccine Product
    Table 99. Serum Institute of India Recent Developments/Updates
    Table 100. Key Raw Materials Lists
    Table 101. Raw Materials Key Suppliers Lists
    Table 102. Poliomycetes Vaccine Distributors List
    Table 103. Poliomycetes Vaccine Customers List
    Table 104. Poliomycetes Vaccine Market Trends
    Table 105. Poliomycetes Vaccine Market Drivers
    Table 106. Poliomycetes Vaccine Market Challenges
    Table 107. Poliomycetes Vaccine Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Poliomycetes Vaccine
    Figure 2. Global Poliomycetes Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Poliomycetes Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Type 1 Product Picture
    Figure 5. Type 2 Product Picture
    Figure 6. Global Poliomycetes Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Poliomycetes Vaccine Market Share by Application in 2023 & 2030
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Others
    Figure 11. Global Poliomycetes Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Poliomycetes Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Poliomycetes Vaccine Sales (2019-2030) & (K Doses)
    Figure 14. Global Poliomycetes Vaccine Average Price (USD/Dose) & (2019-2030)
    Figure 15. Poliomycetes Vaccine Report Years Considered
    Figure 16. Poliomycetes Vaccine Sales Share by Manufacturers in 2023
    Figure 17. Global Poliomycetes Vaccine Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Poliomycetes Vaccine Players: Market Share by Revenue in 2023
    Figure 19. Poliomycetes Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Poliomycetes Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Poliomycetes Vaccine Sales Market Share by Country (2019-2030)
    Figure 22. North America Poliomycetes Vaccine Revenue Market Share by Country (2019-2030)
    Figure 23. U.S. Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Poliomycetes Vaccine Sales Market Share by Country (2019-2030)
    Figure 26. Europe Poliomycetes Vaccine Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Poliomycetes Vaccine Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Poliomycetes Vaccine Revenue Market Share by Region (2019-2030)
    Figure 34. China Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Taiwan Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Poliomycetes Vaccine Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Poliomycetes Vaccine Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Poliomycetes Vaccine Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Poliomycetes Vaccine Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. U.A.E Poliomycetes Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Poliomycetes Vaccine by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Poliomycetes Vaccine by Type (2019-2030)
    Figure 56. Global Poliomycetes Vaccine Price (USD/Dose) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Poliomycetes Vaccine by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Poliomycetes Vaccine by Application (2019-2030)
    Figure 59. Global Poliomycetes Vaccine Price (USD/Dose) by Application (2019-2030)
    Figure 60. Poliomycetes Vaccine Value Chain
    Figure 61. Poliomycetes Vaccine Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions